Medications for Breast Neoplasms

121 results

  • Anastrozole (anastrozole tablets)

    (Anastrozole Tablets)
    Upsher-Smith Laboratories, LLC
    Usage: Anastrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatments of locally advanced or metastatic breast cancer. It is effective following disease progression after tamoxifen therapy.

  • Anastrozole (anastrozole tablets)

    (Anastrozole Tablets)
    AiPing Pharmaceutical Inc
    Usage: Anastrozole is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line and second-line treatment of locally advanced or metastatic breast cancer, particularly following disease progression after tamoxifen therapy.

  • Anastrozole (anastrozole)

    (Anastrozole)
    American Health Packaging
    Usage: Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer, and second-line treatment of advanced breast cancer following disease progression on tamoxifen therapy.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Natco Pharma Limited
    Usage: Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as a second-line treatment for advanced breast cancer after tamoxifen therapy.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Ascend Laboratories, LLC
    Usage: Anastrozole tablets are indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. Responders to previous tamoxifen treatment are essential, as those with ER-negative disease or prior lack of response rarely benefit from anastrozole.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Synthon Pharmaceuticals Inc
    Usage: Anastrozole Tablets are indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown) and second-line treatment after tamoxifen therapy.

  • Anastrozole (anastrozole)

    (Anastrozole)
    NuCare Pharmaceuticals,Inc.
    Usage: Anastrozole tablets are indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown), and second-line treatment for advanced breast cancer after disease progression on tamoxifen.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Ascend Laboratories, LLC
    Usage: Anastrozole tablets are indicated for advanced breast cancer treatment in postmenopausal women whose disease progressed after tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to prior tamoxifen treatment.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Boscogen, Inc.
    Usage: Anastrozole is indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to earlier tamoxifen treatment.

  • Anastrozole (anastrozole)

    (Anastrozole)
    Stason Pharmaceuticals Inc
    Usage: Anastrozole is indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, first-line treatment for hormone receptor-positive or unknown locally advanced/metastatic breast cancer, and second-line treatment for advanced breast cancer following tamoxifen therapy in postmenopausal women.